ClinVar Miner

Submissions for variant NM_015560.2(OPA1):c.1097G>A (p.Arg366Gln) (rs535885178)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000442276 SCV000519056 likely pathogenic not provided 2017-01-16 criteria provided, single submitter clinical testing The R366Q variant in the OPA1 gene has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The R366Q variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The R366Q variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position within the Dynamin-type G domain that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. We interpret R366Q as a likely pathogenic variant; however, the possibility that this is a rare benign variant cannot be completely excluded.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.